Skip to main content
    A

    Armata Pharmaceuticals Inc (ARMP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $2.99
    -0.88 (-22.74%)

    Market Cap: $143.94M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Armata Pharmaceuticals Inc (ARMP) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Armata Pharmaceuticals (ARMP) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Armata Pharmaceuticals reported EPS of -$0.24, above the -$0.57 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    54%(21/39)
    Avg Surprise
    -17.68%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.41
    Range-$0.56 - -$0.24
    4 analysts
    Revenue Consensus
    $525.30K
    RangeN/A
    4 analysts

    Next Report

    ARMP has an expected report date of Mar 17, 2027.

    Earnings History

    Of the 39 quarters below that had an estimate, ARMP beat 21, missed 16 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $3.17M, up 173.3% from $1.16M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.24-$0.57-$0.57 - -$0.54+57.89%BeatN/A20 up, 2 downNov 12, 2026$3.17M
    Jun 30, 2026-$0.27-$0.48-$0.48 - -$0.41+43.75%BeatN/A20 up, 1 downAug 12, 2026$2.51M
    Mar 31, 2026-$3.16-$0.38-$0.38 - -$0.38-731.58%MissN/A10 up, 0 downMay 13, 2026$789000
    Dec 31, 2025-$0.51-$0.19-$0.19 - -$0.19-169.05%MissN/A11 up, 0 downMar 25, 2026$1.08M
    Sep 30, 2025-$0.33-$0.42-$0.42 - -$0.42+21.43%BeatN/A11 up, 0 downNov 12, 2025$1.16M
    Jun 30, 2025-$0.29-$0.39-$0.39 - -$0.39+25.64%BeatN/A10 up, 1 downAug 12, 2025$2.17M
    Mar 31, 2025-$0.20-$0.38-$0.38 - -$0.38+47.37%BeatN/A11 up, 0 downMay 14, 2025$491000
    Dec 31, 2024-$0.23-$0.35-$0.35 - -$0.35+33.80%BeatN/A11 up, 0 downMar 20, 2025$1.24M
    Sep 30, 2024-$0.15-$0.28-$0.28 - -$0.28+46.43%BeatN/A10 up, 0 downNov 13, 2024$2.97M
    Jun 30, 2024-$0.40-$0.36-$0.52 - -$0.36-11.11%MissN/A20 up, 0 downAug 13, 2024N/A
    Mar 31, 2024-$0.33-$0.31-$0.34 - -$0.28-6.45%MissN/A20 up, 0 downMay 7, 2024$966000
    Dec 31, 2023-$0.55-$0.35-$0.36 - -$0.34-57.14%MissN/A20 up, 0 downMar 21, 2024$1.53M
    Sep 30, 2023-$0.32-$0.31-$0.33 - -$0.29-3.23%MissN/A20 up, 0 downNov 14, 2023$1.23M
    Jun 30, 2023-$0.27-$0.37-$0.40 - -$0.35+27.03%BeatN/A20 up, 0 downAug 14, 2023$980000
    Mar 31, 2023-$0.31-$0.32-$0.35 - -$0.29+3.13%BeatN/A20 up, 0 downMay 11, 2023$796000
    Dec 31, 2022-$0.29-$0.28-$0.31 - -$0.25-3.57%MissN/A20 up, 0 downMar 16, 2023$1.05M
    Sep 30, 2022-$0.24-$0.28-$0.28 - -$0.27+14.29%BeatN/A20 up, 0 downNov 9, 2022$1.34M
    Jun 30, 2022-$0.26-$0.23N/A-13.04%MissN/AN/A0 up, 0 downAug 11, 2022$1.88M
    Mar 31, 2022-$0.30-$0.21-$0.22 - -$0.20-42.86%MissN/A20 up, 0 downMay 12, 2022$1.24M
    Dec 31, 2021-$0.23-$0.28-$0.34 - -$0.24+17.86%BeatN/A30 up, 0 downMar 17, 2022$989000
    Sep 30, 2021-$0.25-$0.26-$0.27 - -$0.25+3.85%BeatN/A30 up, 0 downNov 10, 2021$1.25M
    Jun 30, 2021-$0.25-$0.26-$0.28 - -$0.25+3.85%BeatN/A2N/AAug 12, 2021$1.17M
    Mar 31, 2021-$0.27-$0.32-$0.36 - -$0.28+15.63%BeatN/A2N/AMay 13, 2021$1.07M
    Dec 31, 2020-$0.36-$0.29-$0.32 - -$0.25-24.14%MissN/A3N/AMar 18, 2021$504000
    Sep 30, 2020-$0.31-$0.25-$0.28 - -$0.17-24.00%MissN/A3N/ANov 12, 2020$288000
    Jun 30, 2020-$0.26-$0.35-$0.58 - -$0.18+25.71%BeatN/A3N/AAug 13, 2020$31000
    Mar 31, 2020-$0.49-$0.31-$0.35 - -$0.24-58.06%MissN/A2N/AMay 14, 2020N/A
    Dec 31, 2019-$0.48-$0.72-$0.74 - -$0.71+33.33%BeatN/A2N/AMar 19, 2020N/A
    Sep 30, 2019-$0.73-$0.45-$0.53 - -$0.38-62.22%MissN/A2N/ANov 12, 2019N/A
    Jun 30, 2019-$0.56-$0.36-$0.44 - -$0.29-55.56%MissN/A2N/AAug 14, 2019N/A
    Mar 31, 2019-$1.54-$1.54N/A0.00%In lineN/AN/AN/AMay 6, 2019N/A
    Dec 31, 2018-$2.10-$0.98N/A-114.29%MissN/AN/AN/AMar 25, 2019N/A
    Sep 30, 2018-$1.40-$1.40N/A0.00%In lineN/AN/AN/ANov 8, 2018N/A
    Jun 30, 2018-$2.66-$2.80N/A+5.00%BeatN/AN/AN/AAug 9, 2018N/A
    Mar 31, 2018-$3.36-$2.66N/A-26.32%MissN/AN/AN/AMay 15, 2018N/A
    Dec 31, 2017-$3.50-$5.04N/A+30.56%Beat-933.3%N/AN/AMar 14, 2018$20000
    Sep 30, 2017-$1.26-$6.02N/A+79.07%BeatN/AN/AN/ANov 14, 2017$38000
    Jun 30, 2017-$1.21N/AN/AN/AN/AN/AN/AN/AAug 14, 2017$28000
    Mar 31, 2017-$27.16-$114.80N/A+76.34%BeatN/AN/AN/AMay 15, 2017$29000
    Dec 31, 2016$0.42-$42.00N/A+101.00%BeatN/AN/AN/AMar 27, 2017$22000
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.33, after -$1.11 the year before. It was -$257.18 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.33N/A
    Dec 31, 2024-$1.11N/A
    Dec 31, 2023-$1.45N/A
    Dec 31, 2022-$1.09N/A
    Dec 31, 2021-$1.00N/A
    Dec 31, 2020-$1.42N/A
    Dec 31, 2019-$3.31N/A
    Dec 31, 2018-$9.52N/A
    Dec 31, 2017-$33.13N/A
    Dec 31, 2016-$257.18N/A

    Frequently Asked Questions About ARMP

    When is Armata Pharmaceuticals's next earnings date?

    Armata Pharmaceuticals's next earnings report is expected for Mar 17, 2027.

    Did ARMP beat earnings estimates last quarter?

    Yes. Armata Pharmaceuticals reported EPS of -$0.24 for the quarter ended Sep 30, 2026, above the -$0.57 estimate, a 57.89% surprise.

    What EPS do analysts expect from ARMP next quarter?

    The consensus EPS estimate for Armata Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.41 from 4 analysts, with estimates from -$0.56 to -$0.24.

    How often does ARMP beat earnings estimates?

    Armata Pharmaceuticals beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of -83.84%.